Posted on 5/7/19
Ageility Physical Therapy Solutions Partners with National Senior Games Association
NEWTON, Mass.--(BUSINESS WIRE)--Ageility Physical Therapy Solutions, one of the nation’s leading providers of physical, speech and occupational services to older adults, is excited to announce its . . .
Posted on 5/7/19
Bicycle Therapeutics Enters Neuroscience Arena through Collaboration with Dementia Discovery Fund
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle) product platform, today announced . . .
Posted on 5/7/19
Verve Therapeutics Raises $58.5M in Series A Funding Led by GV
Verve Therapeutics, a next-generation cardiovascular company, today announced its launch to discover and develop therapies that safely edit
Posted on 5/7/19
AMAG Pharmaceuticals Announces First Quarter 2019 Financial Results and Provides Corporate Update
WALTHAM, Mass., May 07, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today reported unaudited consolidated financial results for the first quarter ended March 31, . . .
Posted on 5/7/19
Bioasis Announces Private Placement
GUILFORD, Conn.--(BUSINESS WIRE)--BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology for the delivery of therapeutics across the . . .
Posted on 5/7/19
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that, on May . . .
Posted on 5/7/19
Magenta Therapeutics Closes Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to more patients, . . .
Posted on 5/6/19
Covetrus Announces New Partnership with Mars Petcare
PORTLAND, Maine--(BUSINESS WIRE)--Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced a new partnership with Mars Petcare that will help U.S.-based veterinarians . . .
Posted on 5/6/19
Epizyme Provides Business Update and Reports First Quarter 2019 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (Nasdaq: EPZM), a late-stage biopharmaceutical company developing novel epigenetic therapies, today provided business and pipeline updates and reported first quarter 2019 financial . . .
Posted on 5/6/19
Immunogen Inc (IMGN) Q1 2019 Earnings Call Transcript
IMAGE SOURCE: THE MOTLEY FOOL.Immunogen Inc (NASDAQ:IMGN)Q1 2019 Earnings CallMay. 03, 2019, 8:00 a.m. ETContents:Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorGood day, everyone, and welcome to the . . .
Posted on 5/6/19
Dicerna Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational RNA interference (RNAi) therapeutics, today announced that the Compensation Committee . . .
Posted on 5/3/19
Cadence Acquires Arcor Laser Services
Staunton-based Cadence Inc. has acquired the assets of Arcor Laser Services LLC, a laser processing company based in Connecticut.
Posted on 5/3/19
Ironwood Pharmaceuticals Inc (IRWD) Q1 2019 Earnings Call Transcript
IMAGE SOURCE: THE MOTLEY FOOL.Ironwood Pharmaceuticals Inc (NASDAQ:IRWD)Q1 2019 Earnings CallMay. 02, 2019, 8:30 a.m. ETContents:Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorGood morning. My name is James, . . .
Posted on 5/3/19
Anika Announces $50 Million Share Repurchase Program
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary
Posted on 5/3/19
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for patients with kidney disease, granted nine newly-hired . . .
Posted on 5/3/19
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in . . .
Posted on 5/3/19
Translate Bio Announces $47.5 Million Private Placement
LEXINGTON, Mass., GLOBE NEWSWIRE) -- Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to . . .
Posted on 5/2/19
Agios Reports Business Highlights and First Quarter 2019 Financial Results
CAMBRIDGE, Mass., May 02, 2019 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and rare . . .
Posted on 5/2/19
Evelo Biosciences Reports First Quarter 2019 Financial Results and Recent Business Highlights
CAMBRIDGE, Mass., May 02, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical stage biotechnology company developing oral biologics that act on cells in . . .
Posted on 5/2/19
Momenta Pharmaceuticals Reports First Quarter 2019 Financial and Operating Results
CAMBRIDGE, Mass., May 02, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat . . .
Posted on 5/2/19
Biogen's Share Price Will Likely Be Under Pressure If Zolgensma Receives FDA Approval
SummaryBiogen's multiple sclerosis revenues are declining, and likely to see continued revenue declines.Biogen's growth is heavily dependent upon spinal muscular atrophy medication Spinraza. If Novartis' Zolgensma . . .
Posted on 5/2/19
Magenta Therapeutics Prices Public Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to more patients, . . .
Posted on 5/1/19
XRHealth Announces Partnership with Healing HealthCare Systems
XRHealth, formerly known as VRHealth is the leader in extended reality and therapeutic applications, announced today that they are partnering with Healing Healthcare Systems, Inc. to . . .
Posted on 5/1/19
AMAG Pharmaceuticals Announces Grant of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)
WALTHAM, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the Board of Directors of AMAG approved inducement awards to a . . .
Posted on 5/1/19
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on April . . .

